These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 30702848

  • 1. Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.
    Huang Z, Ogasawara D, Seneviratne UI, Cognetta AB, Am Ende CW, Nason DM, Lapham K, Litchfield J, Johnson DS, Cravatt BF.
    ACS Chem Biol; 2019 Feb 15; 14(2):192-197. PubMed ID: 30702848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
    Rocha JF, Santos A, Gama H, Moser P, Falcão A, Pressman P, Wallace Hayes A, Soares-da-Silva P.
    Clin Pharmacol Ther; 2022 Feb 15; 111(2):391-403. PubMed ID: 33998672
    [Abstract] [Full Text] [Related]

  • 5. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
    Kiss LE, Beliaev A, Ferreira HS, Rosa CP, Bonifácio MJ, Loureiro AI, Pires NM, Palma PN, Soares-da-Silva P.
    ChemMedChem; 2018 Oct 22; 13(20):2177-2188. PubMed ID: 30113139
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Commentary on BIA 10-2474.
    Hayes AW.
    Regul Toxicol Pharmacol; 2020 Mar 22; 111():104541. PubMed ID: 31759139
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-clinical toxicology evaluation of BIA 10-2474.
    Hayes AW, Weber K, Moser P, Soares-da-Silva P.
    Crit Rev Toxicol; 2021 Jan 22; 51(1):65-75. PubMed ID: 33528291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.
    Hardisty JF, Harris SB, Hayes WA, Weber K.
    Regul Toxicol Pharmacol; 2020 Mar 22; 111():104555. PubMed ID: 31874201
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD, Bhakta S, Hwang SH, Pakhomova S, Newcomer ME, Morisseau C, Hammock BD.
    Bioorg Med Chem Lett; 2018 Feb 15; 28(4):762-768. PubMed ID: 29366648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.